 |
市場調查報告書
商品編碼
1477214
全球老年藥物市場，依疾病適應症、依形式、依給藥途徑、依配銷通路、依地理位置Global Geriatric Medicines Market, By Disease Indication, By Form, By Route of Administration, By Distribution Channel, By Geography |
||||||
價格
簡介目錄
預計2024年全球老年用藥市值為10,047.1億美元，預估至2031年將達1,5701.8億美元，2024年至2031年年複合成長率(CAGR)為6.6%。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年： | 2023年 | 2024 年市場規模： | 10047.1 億美元 |
| 歷史數據： | 2019年至2023年 | 預測期： | 2024年至2031年 |
| 預測 2024 年至 2031 年複合年成長率： | 6.60% | 2031 年價值預測： | 15,701.8 億美元 |
圖 1. 2024 年全球老年藥物市場佔有率 (%)（依地區）
老年用藥是指用於治療60歲以上族群與年齡相關的疾病和病症的醫療產品。全球不斷成長的老年人口被認為是市場成長的主要動力。根據世界衛生組織 2022 年的估計，到 2050 年，世界人口中約 22% 的年齡將達到 60 歲及以上。隨著預期壽命的延長和出生率的下降，老年人的數量不斷增加，導致心血管疾病、癌症、糖尿病等慢性疾病和生活方式疾病的盛行率不斷增加，需要長期醫療照護。由於目前可用的治療選擇有限，老年藥物為治療常見影響老年人的疾病提供了有針對性的解決方案。開發專門滿足老年人需求的高效醫療基礎設施和醫療解決方案是各地區政府和醫療器材製造商的基本需求。
市場動態：
由於全球老年人口不斷增加、政府加強老年人醫療保健措施以及老年人口中慢性病患病率不斷上升等多種促進因素，全球老年藥物市場預計在預測期內將出現適度成長。老年人口的增加將在不久的將來顯著增加對各類老年藥物的需求。然而，發展中國家老年人疾病診斷和治療率較低以及新藥核准嚴格的監管規範等因素可能會阻礙市場成長。同時，針對老年人的需求開發副作用最小的創新藥和學名藥仍然是市場參與者尚未開發的機會。
研究的主要特點：
- 該報告對全球老年用藥市場進行了深入分析，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模（十億美元）和年複合成長率（CAGR%）。
- 它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
- 這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採取的競爭策略的重要見解。
- 它根據以下參數描述了全球老年藥物市場的主要參與者——公司亮點、產品組合、主要亮點、財務表現和策略。
- 該報告的見解將使行銷人員和公司管理當局能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球老年藥物市場報告迎合了該行業的各個利益相關者，包括投資者、供應商、產品製造商、分銷商、新進業者和財務分析師。
- 利害關係人可以透過用於分析全球老年藥物市場的各種策略矩陣輕鬆做出決策。
目錄
第1章：研究目標與假設
- 研究目標
- 假設
- 縮寫
第 2 章：市場範圍
- 報告說明
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map (COM)
第 3 章：市場動態、法規與趨勢分析
- 市場動態
- 促進要素
- 限制
- 市場機會
- 影響分析
- 市場走向
- 最近的發展
- 收購和合作場景
- 技術概覽
- 監管場景
- 定價分析
- PEST分析
第 4 章：全球老年藥物市場 - 冠狀病毒 (COVID-19) 大流行的影響
- 整體影響
- 政府舉措
- COVID-19 對市場的影響
第 5 章：2019 - 2031 年全球老年藥物市場（依疾病適應症）（十億美元）
- 概述
- 腫瘤學
- 骨科疾病
- 心血管疾病
- 呼吸系統疾病
- 神經系統疾病
- 代謝紊亂
- 其他
第 6 章：全球老年藥物市場，依形式分類，2019 年 - 2031 年（十億美元）
- 概述
- 藥片
- 液體
- 膠囊
- 吸入器
- 專題
- 其他
第 7 章：2019 年至 2031 年全球老年藥物市場（依給藥途徑）（十億美元）
- 概述
- 口服
- 注射用
- 其他
第 8 章：全球老年藥物市場，依配銷通路，2019 - 2031 年（十億美元）
- 概述
- 醫院藥房
- 零售藥局
- 網路藥局
第 9 章：2019 - 2031 年全球老年藥物市場（依地區）（十億美元）
- 介紹
- 北美洲
- 美國
- 加拿大
- 拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
- 歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 歐洲其他地區
- 亞太地區
- 中國
- 印度
- 日本
- 東協
- 澳洲
- 韓國
- 亞太地區其他地區
- 中東
- 海灣合作理事會
- 以色列
- 中東其他地區
- 非洲
- 北非
- 中非
- 南非
第 10 章：競爭格局
- 公司簡介
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Janssen Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Boehringer Ingelheim
- Eli Lilly and Company
- Bristol Myers Squibb
- Daiichi Sankyo Company, Limited
- Bausch Health Companies
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals
- Eisai Co., Ltd.
- Ferring Pharmaceuticals
- UCB
- Evoke Pharma
- Cadila Pharmaceuticals
第 11 章：分析師觀點
- 命運之輪
- 分析師觀點
- 連貫的機會圖
第 12 章：參考文獻與研究方法
- 參考
- 研究方法論
簡介目錄
Product Code: CMI6864
Global geriatric medicines market is estimated to be valued at USD 1,004.71 Bn in 2024 and is expected to reach USD 1,570.18 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.6% from 2024 to 2031.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2023 | Market Size in 2024: | US$ 1,004.71 Bn |
| Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
| Forecast Period 2024 to 2031 CAGR: | 6.60% | 2031 Value Projection: | US$ 1,570.18 Bn |
Figure 1. Global Geriatric Medicines Market Share (%), By Region, 2024
Geriatric medicines refer to the medical products that are used for the treatment of age-related diseases and conditions among people of age 60 years and above. Growing geriatric population across the globe is considered a major driver for the market growth. As per WHO 2022 estimates, by 2050 around 22% of the world's population will be aged 60 years and above. With increased life expectancy and declining birth rates, the number of elderly citizens are increasing that leads to increasing prevalence of chronic and lifestyle conditions such as cardiovascular diseases, cancer, diabetes, and others, requiring long term medical care. With limited treatment options available currently, geriatric medicines provide targeted solutions to treat diseases commonly affecting the aged people. Developing efficient healthcare infrastructure and medical solutions specifically addressing needs of elderly citizens is the essential need for governments and medical device manufacturers across regions.
Market Dynamics:
Global geriatric medicines market is projected to witness moderate growth during the forecast period owing to several drivers such as rising geriatric population worldwide, increasing government initiatives to enhance healthcare for senior citizens, and growing prevalence of chronic diseases among the aged population. The rising pool of elderly will significantly boost demand for various categories of geriatric medicines in the near future. However, factors such as lower diagnosis and treatment rates for diseases among elderly in developing nations and stringent regulatory norms for approval of new drugs may impede the market growth. Meanwhile, development of innovative and generic drugs with minimal side-effects targeted to the requirements of aged remains an untapped opportunity for market players.
Key Features of the Study:
- This report provides in-depth analysis of the global geriatric medicines market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global geriatric medicines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study includes Pfizer Inc., Takeda Pharmaceutical Company Limited, Janssen Pharmaceuticals, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Boehringer Ingelheim, Eli Lilly and Company, Bristol Myers Squibb, Daiichi Sankyo Company, Limited, Bausch Health Companies, Mallinckrodt Pharmaceuticals, Endo Pharmaceuticals, Eisai Co., Ltd., Ferring Pharmaceuticals, UCB, Evoke Pharma, and Cadila Pharmaceuticals
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global geriatric medicines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global geriatric medicines market
Detailed Segmentation-
- Disease Indication:
- Oncology
- Orthopedic Disorders
- Cardiovascular Disorders
- Respiratory Disorders
- Neurological Disorders
- Metabolic Disorders
- Others
- Form:
- Tablet
- Liquid
- Capsule
- Inhalers
- Topical
- Others
- Route of Administration:
- Oral
- Parenteral
- Intravenous
- Intramuscular
- Subcutaneous
- Others
- Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Pfizer Inc.
- Takeda Pharmaceutical Company Limited
- Janssen Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Boehringer Ingelheim
- Eli Lilly and Company
- Bristol Myers Squibb
- Daiichi Sankyo Company, Limited
- Bausch Health Companies
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals
- Eisai Co., Ltd.
- Ferring Pharmaceuticals
- UCB
- Evoke Pharma
- Cadila Pharmaceuticals
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Indication
- Market Snapshot, By Form
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Recent Developments
- Acquisitions and Partnerships Scenario
- Technology Overview
- Regulatory Scenario
- Pricing Analysis
- PEST Analysis
4. Global Geriatric Medicines Market- Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the market
5. Global Geriatric Medicines Market, By Disease Indication, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Orthopedic Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Cardiovascular Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Respiratory Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Neurological Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Metabolic Disorders
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
6. Global Geriatric Medicines Market, By Form, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Tablet
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Liquid
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Capsule
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Inhalers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Topical
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
7. Global Geriatric Medicines Market, By Route of Administration, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Parenteral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Intravenous
- Intramuscular
- Subcutaneous
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
8. Global Geriatric Medicines Market, By Distribution Channel, 2019 - 2031, (USD Bn)
- Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
- Online Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
9. Global Geriatric Medicines Market, By Region, 2019 - 2031, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Indication, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Form, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Pfizer Inc.*
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Janssen Pharmaceuticals
- Sun Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Boehringer Ingelheim
- Eli Lilly and Company
- Bristol Myers Squibb
- Daiichi Sankyo Company, Limited
- Bausch Health Companies
- Mallinckrodt Pharmaceuticals
- Endo Pharmaceuticals
- Eisai Co., Ltd.
- Ferring Pharmaceuticals
- UCB
- Evoke Pharma
- Cadila Pharmaceuticals
11. Analyst View
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
